Reimagining Clinical Trial Recruitment Through a Family-Centered Lens: Caregiver Recommendations for Enhancing Clinical Trial Participation Diversity

This report (20 pages) presents key findings from three roundtable discussions organized by the National Alliance for Caregiving in partnership with Health Leads. The main focus was how to better include caregivers in the development of patient-focused medical products in the United States.

Year: 2022
Languages: English
Format: Document (article, report, guide, etc.)
Dimension(s) of caregiving:
  • Analysis of caregiving support
  • Society and caregiving

Besoin de soutien? →

APPELEZ AU 811 (Info-Santé/Info-Social). Si vous avez besoin de soutien, avez des inquiétudes ou des questions au sujet de votre santé ou celle d’un⋅e proche, composez le 811 afin de parler avec un⋅e professionnel⋅le de la santé ou un⋅e intervenant⋅e, 24 heures par jour, 7 jours par semaine. C’est gratuit et confidentiel.

Si vous souhaitez parler à un⋅e professionnel⋅le spécialisé⋅e en proche aidance en lien avec une situation difficile, obtenir des références ou pour poser des questions, contactez le service Info-Aidant de l’Appui.

Ouvert du lundi au vendredi de 8h à 18h.

1 855 852-7784

[email protected]

www.lappui.org

Pour obtenir du soutien et de l’information pour les personnes proches aidantes dans votre région, consultez le répertoire de ressources de l’Appui ou la liste des organismes membres de Proche aidance Québec.

!

This report (20 pages) presents key findings from three roundtable discussions organized by the National Alliance for Caregiving in partnership with Health Leads. The main focus was how to better include caregivers in the development of patient-focused medical products in the United States.

Held in November and December 2021, the roundtables brought together health and social service professionals, clinical trial experts and caregiver experts, invited to contribute due to their key roles in medical decision-making and other health care tasks. Participants explored how caregivers could contribute more effectively to the development of medical products at different stages of the clinical trial process.